2019–2020 Drug Updates in Hematologic Malignancies

During JADPRO Live Virtual 2020, Heidi D. Finnes, PharmD, BCOP, FHOPA, discussed the pharmacology and indications of medications approved from late 2019 to late 2020 for the management of patients with hematologic malignancies, reviewed pivotal clinical trial data, and covered the adverse events of...

Descripción completa

Detalles Bibliográficos
Autor principal: Finnes, Heidi D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2021
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087224/
https://www.ncbi.nlm.nih.gov/pubmed/34084575
http://dx.doi.org/10.6004/jadpro.2021.12.3.12
_version_ 1783686627943514112
author Finnes, Heidi D.
author_facet Finnes, Heidi D.
author_sort Finnes, Heidi D.
collection PubMed
description During JADPRO Live Virtual 2020, Heidi D. Finnes, PharmD, BCOP, FHOPA, discussed the pharmacology and indications of medications approved from late 2019 to late 2020 for the management of patients with hematologic malignancies, reviewed pivotal clinical trial data, and covered the adverse events of these hematologic medications.
format Online
Article
Text
id pubmed-8087224
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-80872242021-06-02 2019–2020 Drug Updates in Hematologic Malignancies Finnes, Heidi D. J Adv Pract Oncol Meeting Reports During JADPRO Live Virtual 2020, Heidi D. Finnes, PharmD, BCOP, FHOPA, discussed the pharmacology and indications of medications approved from late 2019 to late 2020 for the management of patients with hematologic malignancies, reviewed pivotal clinical trial data, and covered the adverse events of these hematologic medications. Harborside Press LLC 2021-04 2021-04-01 /pmc/articles/PMC8087224/ /pubmed/34084575 http://dx.doi.org/10.6004/jadpro.2021.12.3.12 Text en © 2021 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Reports
Finnes, Heidi D.
2019–2020 Drug Updates in Hematologic Malignancies
title 2019–2020 Drug Updates in Hematologic Malignancies
title_full 2019–2020 Drug Updates in Hematologic Malignancies
title_fullStr 2019–2020 Drug Updates in Hematologic Malignancies
title_full_unstemmed 2019–2020 Drug Updates in Hematologic Malignancies
title_short 2019–2020 Drug Updates in Hematologic Malignancies
title_sort 2019–2020 drug updates in hematologic malignancies
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087224/
https://www.ncbi.nlm.nih.gov/pubmed/34084575
http://dx.doi.org/10.6004/jadpro.2021.12.3.12
work_keys_str_mv AT finnesheidid 20192020drugupdatesinhematologicmalignancies

Ejemplares similares